These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 26902963)
1. Clinical trials: New drug for pancreatic cancer highlights the dual effect of regulatory approvals. Bates SE; Fojo T Nat Rev Clin Oncol; 2016 Apr; 13(4):205-6. PubMed ID: 26902963 [No Abstract] [Full Text] [Related]
12. Safety and efficacy of neoadjuvant FOLFIRINOX treatment in a series of patients with borderline resectable pancreatic ductal adenocarcinoma. Tinchon C; Hubmann E; Pichler A; Keil F; Pichler M; Rabl H; Uggowitzer M; Jilek K; Leitner G; Bauernhofer T Acta Oncol; 2013 Aug; 52(6):1231-3. PubMed ID: 23445338 [No Abstract] [Full Text] [Related]
13. Metastatic pancreatic ductal adenocarcinoma: diagnosis and treatment with a view to the future. Pokorny AMJ; Chin VT; Nagrial AM; Yip D; Chantrill LA Intern Med J; 2018 Jun; 48(6):637-644. PubMed ID: 29898269 [TBL] [Abstract][Full Text] [Related]
14. [nab-Paclitaxel as new therapeutic option for pancreatic cancer]. Michl P Z Gastroenterol; 2013 Nov; 51(11):1329-30. PubMed ID: 24243574 [No Abstract] [Full Text] [Related]
15. Compression of pancreatic tumor blood vessels by hyaluronan is caused by solid stress and not interstitial fluid pressure. Chauhan VP; Boucher Y; Ferrone CR; Roberge S; Martin JD; Stylianopoulos T; Bardeesy N; DePinho RA; Padera TP; Munn LL; Jain RK Cancer Cell; 2014 Jul; 26(1):14-5. PubMed ID: 25026209 [No Abstract] [Full Text] [Related]
16. Response to Chauhan et Al.: interstitial pressure and vascular collapse in pancreas cancer-fluids and solids, measurement and meaning. DelGiorno KE; Carlson MA; Osgood R; Provenzano PP; Brockenbough JS; Thompson CB; Shepard HM; Frost GI; Potter JD; Hingorani SR Cancer Cell; 2014 Jul; 26(1):16-7. PubMed ID: 25026210 [No Abstract] [Full Text] [Related]
17. Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial of chemoradiotherapy and chemotherapy for pancreatic cancer. Ghaneh P; Neoptolemos JP Surg Oncol Clin N Am; 2004 Oct; 13(4):567-87, vii-viii. PubMed ID: 15350935 [TBL] [Abstract][Full Text] [Related]
18. Combination of Anti-miRNAs Oligonucleotides with Low Amounts of Chemotherapeutic Agents for Pancreatic Cancer Therapy. Passadouro M; Faneca H Methods Mol Biol; 2018; 1699():135-154. PubMed ID: 29086375 [TBL] [Abstract][Full Text] [Related]
19. Complete pathological response after FOLFIRINOX for locally advanced pancreatic cancer. The beginning of a new era? Case report and review of the literature. Valeri S; Borzomati D; Nappo G; Perrone G; Santini D; Coppola R Pancreatology; 2014; 14(5):425-30. PubMed ID: 25278312 [TBL] [Abstract][Full Text] [Related]
20. A New Scalpel for the Treatment of Pancreatic Cancer: Targeting Stromal-Derived STAT3 Signaling. Cowan RW; Maitra A; Rhim AD Gastroenterology; 2015 Dec; 149(7):1685-8. PubMed ID: 26526714 [No Abstract] [Full Text] [Related] [Next] [New Search]